|
1. Child-Pugh B【1–9】
2. Alpha-fetoprotein
(≥400 ng/mL)【2,6,8,9】
3. Grade 3 ascites【5,10,11】
4. Bilirubin >3 mg/dL【2,7,8】
5. Performance status >1【3,12】
|
1. >3 liver lesions【1-3】
2. Tumor diameter ≥ 5cm【4-7】
3. Multi-nodular/diffuse
tumour【1,5,8】
4. Bilobar tumour【1,3】
5. Portal vein thrombosis【1,9】
|
1. Non-selective TACE
procedures (lobar/bilobar)【 1-3】
.2. Conventional TACE【4-6】
|
|
1. Dumortier J, et al. Dig Liver Dis 2006;38:125–33
2. Savastano S, et al. J Clin Gastroenterol 1999;28:334–40;
3. Doffoël M, et al. Eur J Cancer 2008;44:528–38;
4. Florio F, et al. Cardiovasc Intervent Radiol 1997;20:23–8;
5. Pietrosi G, et al. J Vasc Intervent Radiol 2009;20:896-902;
6. Yip WM, et al. Hong Kong Med J 2009;15:339-45;
7. Gomes AS, et al. AJR Am J Roentgenol 2009;193:1665-71;
8. Mabed et al. Eur J Cancer Care 2009;18:492-9;
9. Forner et al. Seminars Liver Dis 2010;30:61-74;
10. Cho YK, Cancer 2008;112:352-61;
11. Lladó L, et al. Cancer 2000;88:50–7;
12
|
1. Lladó L, et al. Cancer 2000;88:50–7;
2. Mabed et al. Eur J Cancer Care 2009;18:492-9;
3. Vogl TJ, et al. Radiol 2000;214:349-57;
4. Sotiropoulos GC, et al. Dig
Dis Sci 2009;54:2264-73;
5. Dumortier J, et al. Dig Liver
Dis 2006;38:125–33;
6. Savastano S, et al. J Clin
Gastroenterol 1999; 28:334–40;
7. Doffoël M, et al. Eur J
Cancer 2008; 44:528–38;
8. Lopez RR, et al. Arch Surg
2002; 137:653–658;
9. Sart K, et al. Cancer
1993;72:3202–9.
|
1. Cammà C, et al. Radiology 2002;224:47–54;
2. Yip WM, et al. Hong Kong Med J 2009;15:339-45; 3.
Kothary N, et al. J Vasc Interv Radiol 2007;18:1517–26;
4. Lammer J, et al. Cardiovasc Intervent Radiol 2010; 33:4152.
5. Malagari K et al. Cardiovasc Intervent
Radiol 2010; 33:541-51.
6. Varela M et al. J Hepatol
2007;46:474–81.
|
